Global Functional Service Provider Market

Functional Service Provider Comprehensive Study by Services (Pharmacovigilance, Medical Writing, Statistical Programming, Site Management, Regulatory Affairs, Regulatory Operations, Biostatistics, Others), End-users (Hospitals, Pharmaceutical and Lifesciences Companies, Others) Players and Region - Global Market Outlook to 2030

Functional Service Provider Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Functional Service Provider
A functional service provider (FSP) is a personnel sourcing model in which a clinical research organisation (CRO) delivers staff to biotechnology and pharmaceutical businesses on a contract basis and under the sponsor's procedures to do certain activities in a devoted manner. Clinical trial sponsors benefit from the FSP model because it reduces personnel recruitment and management expenses while also providing quick and flexible access to highly qualified clinical operations and biometrics professionals.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing towards the production technologies, efficiency enhancement and product life. There is various growth opportunity in this market which is captured by leading players via tracking the ongoing process enhancement and huge invest in market growth strategies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Functional Service Provider market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

IQVIA (United States), Syneos Health (United States), Parexel International Corporation (United States), PRA Health Sciences (United States), Pharmaceutical Product Development (United States), Charles River Laboratories (United States), Icon (Ireland), WuXi Apptec (China), Medpace Holdings (United States) and Covance (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Chiltern (United Kingdom) and Fisher Clinical Services (United States).

Segmentation Overview
AMA Research has segmented the market of Global Functional Service Provider market by and Region.



On the basis of geography, the market of Functional Service Provider has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Services, the sub-segment i.e. Pharmacovigilance will boost the Functional Service Provider market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Functional Service Provider market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase in Adoption of New Technologies

Market Growth Drivers:
Increase in R & D Costs

Challenges:
Unavailability of Skilled Resources

Restraints:
Hidden Costs of Outsourcing

Opportunities:
Rising in Consolidation in the Healthcare Market

Market Leaders and their expansionary development strategies
In October 2020, Syneos Health, the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), acquired Synteract, a full-service CRO focused on the rapidly growing emerging biopharma segment. The acquisition will enhance Syneos Health’s leading position in the marketplace, particularly for serving customers across the small to mid-sized (SMID) category – further diversifying the Company’s customer base and expanding support to the high-growth pre-revenue segment.
In 2022, Parexel, a leading global clinical research organization (CRO), and n-Lorem, a nonprofit foundation, announced a new partnership in support of n-Lorem’s effort to discover and provide experimental antisense oligonucleotide (ASO) medicines to nano-rare disease patients (1 to 30 patients worldwide) for free, for life. Parexel brings significant expertise to the partnership, having managed approximately 400 rare disease clinical studies over the past five years that contributed to 17 FDA drug approvals.


Key Target Audience
Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Services
  • Pharmacovigilance
  • Medical Writing
  • Statistical Programming
  • Site Management
  • Regulatory Affairs
  • Regulatory Operations
  • Biostatistics
  • Others

By End-users
  • Hospitals
  • Pharmaceutical and Lifesciences Companies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in R & D Costs
    • 3.3. Market Challenges
      • 3.3.1. Unavailability of Skilled Resources
    • 3.4. Market Trends
      • 3.4.1. Increase in Adoption of New Technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Functional Service Provider, by Services, End-users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Functional Service Provider (Value)
      • 5.2.1. Global Functional Service Provider by: Services (Value)
        • 5.2.1.1. Pharmacovigilance
        • 5.2.1.2. Medical Writing
        • 5.2.1.3. Statistical Programming
        • 5.2.1.4. Site Management
        • 5.2.1.5. Regulatory Affairs
        • 5.2.1.6. Regulatory Operations
        • 5.2.1.7. Biostatistics
        • 5.2.1.8. Others
      • 5.2.2. Global Functional Service Provider by: End-users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Pharmaceutical and Lifesciences Companies
        • 5.2.2.3. Others
      • 5.2.3. Global Functional Service Provider Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Functional Service Provider: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. IQVIA (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Syneos Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Parexel International Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. PRA Health Sciences (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pharmaceutical Product Development (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Charles River Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Icon (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. WuXi Apptec (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Medpace Holdings (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Covance (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Functional Service Provider Sale, by Services, End-users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Functional Service Provider (Value)
      • 7.2.1. Global Functional Service Provider by: Services (Value)
        • 7.2.1.1. Pharmacovigilance
        • 7.2.1.2. Medical Writing
        • 7.2.1.3. Statistical Programming
        • 7.2.1.4. Site Management
        • 7.2.1.5. Regulatory Affairs
        • 7.2.1.6. Regulatory Operations
        • 7.2.1.7. Biostatistics
        • 7.2.1.8. Others
      • 7.2.2. Global Functional Service Provider by: End-users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Pharmaceutical and Lifesciences Companies
        • 7.2.2.3. Others
      • 7.2.3. Global Functional Service Provider Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Functional Service Provider: by Services(USD Million)
  • Table 2. Functional Service Provider Pharmacovigilance , by Region USD Million (2018-2023)
  • Table 3. Functional Service Provider Medical Writing , by Region USD Million (2018-2023)
  • Table 4. Functional Service Provider Statistical Programming , by Region USD Million (2018-2023)
  • Table 5. Functional Service Provider Site Management , by Region USD Million (2018-2023)
  • Table 6. Functional Service Provider Regulatory Affairs , by Region USD Million (2018-2023)
  • Table 7. Functional Service Provider Regulatory Operations , by Region USD Million (2018-2023)
  • Table 8. Functional Service Provider Biostatistics , by Region USD Million (2018-2023)
  • Table 9. Functional Service Provider Others , by Region USD Million (2018-2023)
  • Table 10. Functional Service Provider: by End-users(USD Million)
  • Table 11. Functional Service Provider Hospitals , by Region USD Million (2018-2023)
  • Table 12. Functional Service Provider Pharmaceutical and Lifesciences Companies , by Region USD Million (2018-2023)
  • Table 13. Functional Service Provider Others , by Region USD Million (2018-2023)
  • Table 14. South America Functional Service Provider, by Country USD Million (2018-2023)
  • Table 15. South America Functional Service Provider, by Services USD Million (2018-2023)
  • Table 16. South America Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 17. Brazil Functional Service Provider, by Services USD Million (2018-2023)
  • Table 18. Brazil Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 19. Argentina Functional Service Provider, by Services USD Million (2018-2023)
  • Table 20. Argentina Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 21. Rest of South America Functional Service Provider, by Services USD Million (2018-2023)
  • Table 22. Rest of South America Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 23. Asia Pacific Functional Service Provider, by Country USD Million (2018-2023)
  • Table 24. Asia Pacific Functional Service Provider, by Services USD Million (2018-2023)
  • Table 25. Asia Pacific Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 26. China Functional Service Provider, by Services USD Million (2018-2023)
  • Table 27. China Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 28. Japan Functional Service Provider, by Services USD Million (2018-2023)
  • Table 29. Japan Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 30. India Functional Service Provider, by Services USD Million (2018-2023)
  • Table 31. India Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 32. South Korea Functional Service Provider, by Services USD Million (2018-2023)
  • Table 33. South Korea Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 34. Taiwan Functional Service Provider, by Services USD Million (2018-2023)
  • Table 35. Taiwan Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 36. Australia Functional Service Provider, by Services USD Million (2018-2023)
  • Table 37. Australia Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 38. Rest of Asia-Pacific Functional Service Provider, by Services USD Million (2018-2023)
  • Table 39. Rest of Asia-Pacific Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 40. Europe Functional Service Provider, by Country USD Million (2018-2023)
  • Table 41. Europe Functional Service Provider, by Services USD Million (2018-2023)
  • Table 42. Europe Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 43. Germany Functional Service Provider, by Services USD Million (2018-2023)
  • Table 44. Germany Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 45. France Functional Service Provider, by Services USD Million (2018-2023)
  • Table 46. France Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 47. Italy Functional Service Provider, by Services USD Million (2018-2023)
  • Table 48. Italy Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 49. United Kingdom Functional Service Provider, by Services USD Million (2018-2023)
  • Table 50. United Kingdom Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 51. Netherlands Functional Service Provider, by Services USD Million (2018-2023)
  • Table 52. Netherlands Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 53. Rest of Europe Functional Service Provider, by Services USD Million (2018-2023)
  • Table 54. Rest of Europe Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 55. MEA Functional Service Provider, by Country USD Million (2018-2023)
  • Table 56. MEA Functional Service Provider, by Services USD Million (2018-2023)
  • Table 57. MEA Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 58. Middle East Functional Service Provider, by Services USD Million (2018-2023)
  • Table 59. Middle East Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 60. Africa Functional Service Provider, by Services USD Million (2018-2023)
  • Table 61. Africa Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 62. North America Functional Service Provider, by Country USD Million (2018-2023)
  • Table 63. North America Functional Service Provider, by Services USD Million (2018-2023)
  • Table 64. North America Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 65. United States Functional Service Provider, by Services USD Million (2018-2023)
  • Table 66. United States Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 67. Canada Functional Service Provider, by Services USD Million (2018-2023)
  • Table 68. Canada Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 69. Mexico Functional Service Provider, by Services USD Million (2018-2023)
  • Table 70. Mexico Functional Service Provider, by End-users USD Million (2018-2023)
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Functional Service Provider: by Services(USD Million)
  • Table 82. Functional Service Provider Pharmacovigilance , by Region USD Million (2025-2030)
  • Table 83. Functional Service Provider Medical Writing , by Region USD Million (2025-2030)
  • Table 84. Functional Service Provider Statistical Programming , by Region USD Million (2025-2030)
  • Table 85. Functional Service Provider Site Management , by Region USD Million (2025-2030)
  • Table 86. Functional Service Provider Regulatory Affairs , by Region USD Million (2025-2030)
  • Table 87. Functional Service Provider Regulatory Operations , by Region USD Million (2025-2030)
  • Table 88. Functional Service Provider Biostatistics , by Region USD Million (2025-2030)
  • Table 89. Functional Service Provider Others , by Region USD Million (2025-2030)
  • Table 90. Functional Service Provider: by End-users(USD Million)
  • Table 91. Functional Service Provider Hospitals , by Region USD Million (2025-2030)
  • Table 92. Functional Service Provider Pharmaceutical and Lifesciences Companies , by Region USD Million (2025-2030)
  • Table 93. Functional Service Provider Others , by Region USD Million (2025-2030)
  • Table 94. South America Functional Service Provider, by Country USD Million (2025-2030)
  • Table 95. South America Functional Service Provider, by Services USD Million (2025-2030)
  • Table 96. South America Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 97. Brazil Functional Service Provider, by Services USD Million (2025-2030)
  • Table 98. Brazil Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 99. Argentina Functional Service Provider, by Services USD Million (2025-2030)
  • Table 100. Argentina Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 101. Rest of South America Functional Service Provider, by Services USD Million (2025-2030)
  • Table 102. Rest of South America Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 103. Asia Pacific Functional Service Provider, by Country USD Million (2025-2030)
  • Table 104. Asia Pacific Functional Service Provider, by Services USD Million (2025-2030)
  • Table 105. Asia Pacific Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 106. China Functional Service Provider, by Services USD Million (2025-2030)
  • Table 107. China Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 108. Japan Functional Service Provider, by Services USD Million (2025-2030)
  • Table 109. Japan Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 110. India Functional Service Provider, by Services USD Million (2025-2030)
  • Table 111. India Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 112. South Korea Functional Service Provider, by Services USD Million (2025-2030)
  • Table 113. South Korea Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 114. Taiwan Functional Service Provider, by Services USD Million (2025-2030)
  • Table 115. Taiwan Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 116. Australia Functional Service Provider, by Services USD Million (2025-2030)
  • Table 117. Australia Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 118. Rest of Asia-Pacific Functional Service Provider, by Services USD Million (2025-2030)
  • Table 119. Rest of Asia-Pacific Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 120. Europe Functional Service Provider, by Country USD Million (2025-2030)
  • Table 121. Europe Functional Service Provider, by Services USD Million (2025-2030)
  • Table 122. Europe Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 123. Germany Functional Service Provider, by Services USD Million (2025-2030)
  • Table 124. Germany Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 125. France Functional Service Provider, by Services USD Million (2025-2030)
  • Table 126. France Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 127. Italy Functional Service Provider, by Services USD Million (2025-2030)
  • Table 128. Italy Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 129. United Kingdom Functional Service Provider, by Services USD Million (2025-2030)
  • Table 130. United Kingdom Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 131. Netherlands Functional Service Provider, by Services USD Million (2025-2030)
  • Table 132. Netherlands Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 133. Rest of Europe Functional Service Provider, by Services USD Million (2025-2030)
  • Table 134. Rest of Europe Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 135. MEA Functional Service Provider, by Country USD Million (2025-2030)
  • Table 136. MEA Functional Service Provider, by Services USD Million (2025-2030)
  • Table 137. MEA Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 138. Middle East Functional Service Provider, by Services USD Million (2025-2030)
  • Table 139. Middle East Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 140. Africa Functional Service Provider, by Services USD Million (2025-2030)
  • Table 141. Africa Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 142. North America Functional Service Provider, by Country USD Million (2025-2030)
  • Table 143. North America Functional Service Provider, by Services USD Million (2025-2030)
  • Table 144. North America Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 145. United States Functional Service Provider, by Services USD Million (2025-2030)
  • Table 146. United States Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 147. Canada Functional Service Provider, by Services USD Million (2025-2030)
  • Table 148. Canada Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 149. Mexico Functional Service Provider, by Services USD Million (2025-2030)
  • Table 150. Mexico Functional Service Provider, by End-users USD Million (2025-2030)
  • Table 151. Research Programs/Design for This Report
  • Table 152. Key Data Information from Secondary Sources
  • Table 153. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Functional Service Provider: by Services USD Million (2018-2023)
  • Figure 5. Global Functional Service Provider: by End-users USD Million (2018-2023)
  • Figure 6. South America Functional Service Provider Share (%), by Country
  • Figure 7. Asia Pacific Functional Service Provider Share (%), by Country
  • Figure 8. Europe Functional Service Provider Share (%), by Country
  • Figure 9. MEA Functional Service Provider Share (%), by Country
  • Figure 10. North America Functional Service Provider Share (%), by Country
  • Figure 11. Global Functional Service Provider share by Players 2023 (%)
  • Figure 12. Global Functional Service Provider share by Players (Top 3) 2023(%)
  • Figure 13. Global Functional Service Provider share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. IQVIA (United States) Revenue, Net Income and Gross profit
  • Figure 16. IQVIA (United States) Revenue: by Geography 2023
  • Figure 17. Syneos Health (United States) Revenue, Net Income and Gross profit
  • Figure 18. Syneos Health (United States) Revenue: by Geography 2023
  • Figure 19. Parexel International Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Parexel International Corporation (United States) Revenue: by Geography 2023
  • Figure 21. PRA Health Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 22. PRA Health Sciences (United States) Revenue: by Geography 2023
  • Figure 23. Pharmaceutical Product Development (United States) Revenue, Net Income and Gross profit
  • Figure 24. Pharmaceutical Product Development (United States) Revenue: by Geography 2023
  • Figure 25. Charles River Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Charles River Laboratories (United States) Revenue: by Geography 2023
  • Figure 27. Icon (Ireland) Revenue, Net Income and Gross profit
  • Figure 28. Icon (Ireland) Revenue: by Geography 2023
  • Figure 29. WuXi Apptec (China) Revenue, Net Income and Gross profit
  • Figure 30. WuXi Apptec (China) Revenue: by Geography 2023
  • Figure 31. Medpace Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 32. Medpace Holdings (United States) Revenue: by Geography 2023
  • Figure 33. Covance (United States) Revenue, Net Income and Gross profit
  • Figure 34. Covance (United States) Revenue: by Geography 2023
  • Figure 35. Global Functional Service Provider: by Services USD Million (2025-2030)
  • Figure 36. Global Functional Service Provider: by End-users USD Million (2025-2030)
  • Figure 37. South America Functional Service Provider Share (%), by Country
  • Figure 38. Asia Pacific Functional Service Provider Share (%), by Country
  • Figure 39. Europe Functional Service Provider Share (%), by Country
  • Figure 40. MEA Functional Service Provider Share (%), by Country
  • Figure 41. North America Functional Service Provider Share (%), by Country
List of companies from research coverage that are profiled in the study
  • IQVIA (United States)
  • Syneos Health (United States)
  • Parexel International Corporation (United States)
  • PRA Health Sciences (United States)
  • Pharmaceutical Product Development (United States)
  • Charles River Laboratories (United States)
  • Icon (Ireland)
  • WuXi Apptec (China)
  • Medpace Holdings (United States)
  • Covance (United States)
Additional players considered in the study are as follows:
Chiltern (United Kingdom) , Fisher Clinical Services (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 220 Pages 81 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Functional Service Provider Market Quantitative research analysis
Global Functional Service Provider Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as IQVIA (United States), Syneos Health (United States), Parexel International Corporation (United States), PRA Health Sciences (United States), Pharmaceutical Product Development (United States), Charles River Laboratories (United States), Icon (Ireland), WuXi Apptec (China), Medpace Holdings (United States) and Covance (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase in Adoption of New Technologies" is seen as one of major influencing trends for Functional Service Provider Market during projected period 2023-2030.
The Functional Service Provider market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Functional Service Provider Market Report?

Have a Query? Click Here

Other Related Reports

Doctor House Call Comprehensive Study by Call Medium (Mobile Based Call, App-based Appointment), Services (Comprehensive Medical Exam & Evaluation, Lab Tests, Wound Care, Memory and Dementia Care, Ro...
$ 3800
Medical Transseptal Access System Comprehensive Study by Type (Integrated Transseptal Devices, Non-integrated Transseptal Devices), Application (Children, Adult), Transseptal Access (Transseptal Acce...
$ 3800
Implant Intraocular Lens Comprehensive Study by Type (Accommodative Intraocular Lens, Monofocal Intraocular Lens, Multifocal Intraocular Lens, Toric Intraocular Lens), End-users (Hospitals, Ophthalmi...
$ 3500
Medical Uniforms Comprehensive Study by Type (Professional Apparel, Patient Apparel, First Aid Clothing, Wraps and Towels, Others), Usage (Reusable, Disposable), Distribution Channel (Direct Tender, ...
$ 3800
Home Therapy Machine Comprehensive Study by Application (Musculoskeletal Applications, Neurological Applications, Cardiovascular & Pulmonary Applications, Others), Distribution Channel (Hospital Phar...
$ 3500
Medical Visualization Solution Comprehensive Study by Type (MRI equipment, CT equipment, X-ray equipment, Ultrasound, Molecular Imaging), Clinical Application (Radiology/Interventional Radiology, Car...
$ 3800